VTYX: Ventyx Biosciences Company Short-Term Debt
Ventyx Biosciences (VTYX) is currently executing a tactical pivot, reducing research expenditures to preserve assets. This price chart reflects a metric of 0.00. Business stability is underpinned by skilled specialists and a pipeline of promising developments in the US. Ventyx Biosciences (VTYX) specializes in creating innovative tools for immune system enhancement and the therapy of related pathologies.
Metric breakdowns and analytics for Ventyx Biosciences, Inc (VTYX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Ventyx Biosciences|VTYX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ventyx Biosciences|VTYX - Company Total Debt|Debt to Book Capitalization Ratio Ventyx Biosciences, Inc.|VTYX - Company Long-Term Liabilities|Company Current Liabilities Ventyx Biosciences|Quick Liquidity ventyxbio.com
- net income and valuation multiples indicators:
Initial company analysis:VTYX - Ventyx Biosciences, Inc.
Fundamental analysis of Ventyx Biosciences (VTYX) requires precise liquidity monitoring to assess the biotech's stability. This indicator captures obligations with maturities of up to twelve months, eliminating the lag associated with quarterly reports. The dynamics of current borrowings reflect debt management efficiency or access to bank financing. For Ventyx Biosciences (VTYX), this is critical during the development of unique TYK2/S1P1 inhibitors. Controlling short-term liabilities confirms the company's financial readiness for the commercialization of drugs in the inelastic colitis treatment segment.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB: Company Current Liabilities|ZBIO: Company Short-Term Debt|IMNM: Company Short-Term Debts|Short-Term Debt gossamerbio.com (GOSS)|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|Company Short-Term Indebtedness SEPN (Septerna, Inc.)|Company Current Liabilities PVLA (Pieris Pharmaceuticals Inc)|Amount of Current Liabilities SVRA|Rigel Pharmaceuticals - Company Current Liabilities|anaptysbio.com (ANAB) - Short-Term Debt|ATXS: Company Current Liabilities|ENGN (enGene Holdings Inc) - Company Short-Term Indebtedness|RAPT (RAPT Therapeutics) - Company Current Liabilities|Aerovate Therapeutics - Company Short-Term Loans and Borrowings|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|Company Short-Term Debt KYTX|Company Short-Term Debts TLSA|Short-Term Debt Volume Cabaletta Bio Inc.|Company Short-Term Debt Theratechnologies Inc THTX|Avalo Therapeutics Inc (AVTX) - Short-Term Debt|ELDN - Company Short-Term Debt|Short-Term Debt Volume agenusbio.com AGEN|CLYM: Company Short-Term Debts|Company Current Liabilities zurabio.com|ATYR (aTyr) - Company Short-Term Debts|Adagene Corp (ADAG) - Short-Term Debt Volume|Company Short-Term Debts IMA|STTK - Short-Term Debt|Company Short-Term Debt Equillium EQ|CNTB: Company Short-Term Indebtedness|Immunic Inc - Company Short-Term Debts|Atara Biotherapeutics (ATRA) - Company Current Liabilities|IFRX: Company Short-Term Debts|Short-Term Debt x4pharma.com (XFOR)|Company Short-Term Debt Adicet Bio Inc.|Celularity Corp (CELU) - Short-Term Debt Volume|Company Current Liabilities INMB (INmune Bio Corp)|Company Short-Term Debt BRNS (Barinthus Biotherapeutics Corp)|Kezar Life Sciences - Company Current Liabilities|Amount of Current Liabilities SABS (sabbiotherapeutics.com)|AKTX: Company Current Liabilities|Short-Term Debt Enlivex Therapeutics|QTTB (q32bio.com) - Company Current Liabilities|Company Short-Term Indebtedness GOVX|Company Short-Term Debt Edesa Biotech, Inc.|ibioinc.com - Current Liabilities|Company Short-Term Debts CARM|XTLB (XTL Biopharmaceuticals Ltd) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Debts HCW Biologics, Inc. HCWB|APVO - Company Short-Term Debt|Company Short-Term Loans and Borrowings AIM (aimimmuno.com)|aditxt.com (ADTX) - Company Short-Term Debt|Company Current Liabilities GRI Bio Inc|XRTX (XORTX) - Company Short-Term Debts|Company Short-Term Debts Vyome Therapeutics|Company Current Liabilities REVB (Revelation Biosciences)|INDP (indaptusrx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Short-Term Debt Volume CalciMedica Inc (CALI)|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Current Liabilities ITOS|Company Short-Term Debts Ocean Biomedical Inc|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Third Harmonic Bio Inc - Company Short-Term Indebtedness